Can Extended Letrozole Therapy Reduce Breast Cancer Recurrence Risk?

Leggi l'articolo originale


The GIM4 study looked at the effect of 2 to 3 years vs 5 years of letrozole on risk of recurrence in HR-positive early breast cancer.

Lascia un commento